ArticleTransgenic research2011
Proteomic analysis of MON810 and comparable non-GM maize varieties grown in agricultural fields.
Article in Transgenic research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 64 citations in OpenAlex.
- Evaluation of the Unintended Effects of Herbicide-Resistant Soybean Seeds via TMT Quantitative Proteomics and Flavonoid-Targeted Metabolomics.International journal of molecular sciences · 2026Article
- Proteomic Analysis ofPlants (Basel, Switzerland) · 2023Article
- Untargeted Proteomics-Based Approach to Investigate Unintended Changes in Genetically Modified Maize for Environmental Risk Assessment Purpose.Frontiers in toxicology · 2021Article
- Comparative Proteomics of Phytase-transgenic Maize Seeds Indicates Environmental Influence is More Important than that of Gene Insertion.Scientific reports · 2019Article
- Comparative analysis of miRNA expression profiles in transgenic and non-transgenic rice using miRNA-Seq.Scientific reports · 2018Article
- Proteomic analysis of phytase transgenic and non-transgenic maize seeds.Scientific reports · 2017Article
- Molecular responses of genetically modified maize to abiotic stresses as determined through proteomic and metabolomic analyses.PloS one · 2017Article
- Potential subchronic food safety of the stacked trait transgenic maize GH5112E-117C in Sprague-Dawley rats.Transgenic research · 2016Article
- Comparative Proteomics of Leaves from Phytase-Transgenic Maize and Its Non-transgenic Isogenic Variety.Frontiers in plant science · 2016Article
- A proteomic analysis of seeds from Bt-transgenic Brassica napus and hybrids with wild B. juncea.Scientific reports · 2015Article
- Comparative proteomics of Bt-transgenic and non-transgenic cotton leaves.Proteome science · 2015Article
- Effect of stacking insecticidal cry and herbicide tolerance epsps transgenes on transgenic maize proteome.BMC plant biology · 2014Article
- Comparative proteomic analysis of genetically modified maize grown under different agroecosystems conditions in Brazil.Proteome science · 2013Article
- Proteomic evaluation of genetically modified crops: current status and challenges.Frontiers in plant science · 2013Article
- Evaluation of genetically engineered crops using transcriptomic, proteomic, and metabolomic profiling techniques.Plant physiology · 2011Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Worldwide maize is the second major agricultural commodity and around one-fourth is currently biotech, with significant application of the insect resistant event MON810 particularly in the European Union. Grains are the major commercialized part of the plant, and can be harvested after maturity (for food and feed purposes) or at late milky-starchy stage (for forage uses, with the whole plant). We assessed possible proteomic unintended effects of the MON810 transgene using two-dimensional gel electrophoresis coupled to mass spectrometry. To keep in a realistic scenario we used plants grown in agricultural fields in a region where ~50% of maize was MON810, and analyzed grains at milky-starchy stage. In maize, differential transcripts and metabolites between GM and comparable non-GM varieties tend to be variety specific. Thus, we analyzed two variety pairs, DKC6575/Tietar and PR33P67/PR33P66 which are considered representative of Food and Agriculture Organization 700 and 600 varieties commercially grown in the region. MON810 and non-GM milky-starchy grains had virtually identical proteomic patterns, with a very small number of spots showing fold-variations in the 1-1.8 range. They were all variety specific and had divergent identities and functions. Although 2DE allows the analysis of a limited dataset our results support substantial equivalence between MON810 and comparable non-GM varieties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.